These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. [Agranulocytosis caused by perindopril]. Hamidou M; Glemarec J; Elia-Foeillet S; Acard F; Chiffoleau A; Grolleau JY Ann Med Interne (Paris); 1996; 147(7):523-4. PubMed ID: 9092368 [No Abstract] [Full Text] [Related]
83. The effect of local anesthetics against planktonic forms and film formation of Faustova M; Nazarchuk O; Dmytriiev D; Babina Y; Nazarchuk H; Dudar A Front Microbiol; 2023; 14():1199899. PubMed ID: 37720142 [TBL] [Abstract][Full Text] [Related]
84. Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Šíma M; Bobek D; Cihlářová P; Ryšánek P; Roušarová J; Beroušek J; Kuchař M; Vymazal T; Slanař O Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015253 [TBL] [Abstract][Full Text] [Related]
85. Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using Bhatt S; Dhiman S; Kumar V; Gour A; Manhas D; Sharma K; Ojha PK; Nandi U ACS Omega; 2022 Jun; 7(23):20321-20331. PubMed ID: 35721953 [TBL] [Abstract][Full Text] [Related]
86. Drug-Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes. Klomp F; Wenzel C; Drozdzik M; Oswald S Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33322313 [TBL] [Abstract][Full Text] [Related]
87. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. Wang Y; Bahar MA; Jansen AME; Kocks JWH; Alffenaar JC; Hak E; Wilffert B; Borgsteede SD J Antimicrob Chemother; 2019 Oct; 74(10):2848-2864. PubMed ID: 31127283 [TBL] [Abstract][Full Text] [Related]
88. Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams. Bolhuis MS; Panday PN; Pranger AD; Kosterink JG; Alffenaar JW Pharmaceutics; 2011 Nov; 3(4):865-913. PubMed ID: 24309312 [TBL] [Abstract][Full Text] [Related]
89. [Local anesthetic procedures in dermatology: Part 1: principles]. Dill-Müller D Hautarzt; 2012 Jan; 63(1):53-62; quiz 63-4. PubMed ID: 22273997 [TBL] [Abstract][Full Text] [Related]
90. Effect of ciprofloxacin and ibuprofen on the in vitro metabolism of rosiglitazone and oral pharmacokinetics of rosiglitazone in healthy human volunteers. Kumar JN; Devi P; Narasu L; Mullangi R Eur J Drug Metab Pharmacokinet; 2008; 33(4):237-42. PubMed ID: 19230597 [TBL] [Abstract][Full Text] [Related]
91. A mechanistic approach for the scaling of clearance in children. Edginton AN; Schmitt W; Voith B; Willmann S Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850 [TBL] [Abstract][Full Text] [Related]
92. Effect of propofol on ropivacaine metabolism in human liver microsomes. Osaka Y; Inomata S; Tanaka E; Nakamura T; Honda K; Miyabe M; Toyooka H; Tanaka M J Anesth; 2006; 20(1):60-3. PubMed ID: 16421682 [TBL] [Abstract][Full Text] [Related]
93. Ropivacaine: a review of its use in regional anaesthesia and acute pain management. Simpson D; Curran MP; Oldfield V; Keating GM Drugs; 2005; 65(18):2675-717. PubMed ID: 16392884 [TBL] [Abstract][Full Text] [Related]
94. Metabolism of ropivacaine in humans is mediated by CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors. Arlander E; Ekström G; Alm C; Carrillo JA; Bielenstein M; Böttiger Y; Bertilsson L; Gustafsson LL Clin Pharmacol Ther; 1998 Nov; 64(5):484-91. PubMed ID: 9834040 [TBL] [Abstract][Full Text] [Related]
95. Effect of rifampin and tobacco smoking on the pharmacokinetics of ropivacaine. Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ Clin Pharmacol Ther; 2001 Oct; 70(4):344-50. PubMed ID: 11673750 [TBL] [Abstract][Full Text] [Related]
96. The effect of erythromycin, fluvoxamine, and their combination on the pharmacokinetics of ropivacaine. Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT Anesth Analg; 2000 Nov; 91(5):1207-12. PubMed ID: 11049910 [TBL] [Abstract][Full Text] [Related]
97. Effect of clarithromycin and itraconazole on the pharmacokinetics of ropivacaine. Jokinen MJ; Ahonen J; Neuvonen PJ; Olkkola KT Pharmacol Toxicol; 2001 Apr; 88(4):187-91. PubMed ID: 11322176 [TBL] [Abstract][Full Text] [Related]
98. The pharmacokinetics of ropivacaine in hepatic and renal insufficiency. Jokinen MJ Best Pract Res Clin Anaesthesiol; 2005 Jun; 19(2):269-74. PubMed ID: 15966497 [TBL] [Abstract][Full Text] [Related]
99. Effect of ciprofloxacin on the pharmacokinetics of ropivacaine. Jokinen MJ; Olkkola KT; Ahonen J; Neuvonen PJ Eur J Clin Pharmacol; 2003 Feb; 58(10):653-7. PubMed ID: 12610740 [TBL] [Abstract][Full Text] [Related]